Renaissance Technologies’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Renaissance Technologies’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-332,333	Closed	-$206K	–	3877
2018 Q4	$206K	Buy	332,333 +145,233	+78%	+$151K	﹤0.01%	3128
2018 Q3	$243K	Buy	187,100 +82,000	+78%	+$127K	﹤0.01%	3090
2018 Q2	$142K	Buy	+105,100	New	+$161K	﹤0.01%	3114

Renaissance Technologies's AST Position: Q1 2019 in Review

Renaissance Technologies sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 332,333 shares — an estimated $206K sold.

Renaissance Technologies first reported a position in AST in Q2 2018 and held it in 3 quarters. The position peaked at $243K in Q3 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

Renaissance Technologies reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
Renaissance Technologies sold 332,333 Asterias Biotherapeutics Inc. Series A shares in Q1 2019, an estimated $206K.
Renaissance Technologies first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2018 and held it in 3 quarters.
Renaissance Technologies's Asterias Biotherapeutics Inc. Series A position peaked at $243K in Q3 2018.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.